Is TransCode Therapeutics Inc (NASDAQ: RNAZ) Back In The Buying Zone?
Currently, there are 0.70M common shares owned by the public and among those 0.63M shares have been available to trade. The company’s stock has a 5-day price change of 44.00% and -82.26% over the past three months. RNAZ shares are trading -66.77% year to date (YTD), with the 12-month market performance down to -95.08% lower. […]
TransCode Therapeutics Inc (NASDAQ: RNAZ) Not A Good Play Anymore?
TransCode Therapeutics Inc (RNAZ) concluded trading on Wednesday at a closing price of $1.02, with 10.36 million shares of worth about $10.57 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -87.91% during that period and on March 12, 2025 the price saw a […]
TransCode Therapeutics Inc (RNAZ) Outlook Starting To Look Brighter?
TransCode Therapeutics Inc (RNAZ) concluded trading on Thursday at a closing price of $0.68, with 3.53 million shares of worth about $2.4 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -99.16% during that period and on Thursday, February 01 price saw a loss […]
Following The Money: Institution’s Growing Stake In TransCode Therapeutics Inc (NASDAQ: RNAZ)
TransCode Therapeutics Inc (RNAZ) concluded trading on 01/11/24 at a closing price of $0.14, with 14.4 million shares of worth about $2.02 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -94.85% during that period and on Thursday the price saw a gain of […]
